首页 > 最新文献

Missouri medicine最新文献

英文 中文
Recent Advances in Rheumatology. 风湿病学最新进展。
Pub Date : 2025-09-01
Kent Kwas Huston

There are too many topics for this article to represent a comprehensive and thorough review of rheumatology. Instead, this paper will focus on advances which would be of interest to a general medical audience. Highlighted are the more commonly encountered rheumatic diseases as well as uncommon disorders that are of significant interest as they expand our understanding of biologic mechanisms of disease. We will take a tour from rheumatoid arthritis to a fascinating new entity called VEXAS. The purpose of this review is to broaden knowledge of mechanistic and therapeutic advances in rheumatology and foster a greater appreciation of current management principles related to autoimmune rheumatic disease.

有太多的主题,这篇文章代表风湿病学的全面和彻底的审查。相反,本文将重点介绍一般医学受众感兴趣的进展。重点强调的是更常见的风湿病以及不常见的疾病,因为它们扩展了我们对疾病的生物学机制的理解,因此具有重要的兴趣。我们将从类风湿关节炎开始介绍一种叫做VEXAS的迷人的新实体。本综述的目的是拓宽风湿病的机制和治疗进展的知识,并促进对自身免疫性风湿病相关的当前管理原则的更好的理解。
{"title":"Recent Advances in Rheumatology.","authors":"Kent Kwas Huston","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There are too many topics for this article to represent a comprehensive and thorough review of rheumatology. Instead, this paper will focus on advances which would be of interest to a general medical audience. Highlighted are the more commonly encountered rheumatic diseases as well as uncommon disorders that are of significant interest as they expand our understanding of biologic mechanisms of disease. We will take a tour from rheumatoid arthritis to a fascinating new entity called VEXAS. The purpose of this review is to broaden knowledge of mechanistic and therapeutic advances in rheumatology and foster a greater appreciation of current management principles related to autoimmune rheumatic disease.</p>","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 5","pages":"433-439"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145355792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnant for Nine Months, Postpartum for Life: Long-term Implications of Pregnancy Related Conditions. 怀孕9个月,产后生活:妊娠相关疾病的长期影响。
Pub Date : 2025-09-01
Helen Suzanne Hill, Kelly Jo Sandri

Maternal mortality in the state of Missouri remains among the highest in the nation. Recognizing that the burden of making corrective actions does not rest solely with obstetric providers, it is time to consider how pregnancy affects our patients before, during, and after childbirth. Reviewing pregnancy history and pregnancy intention can be a chance to address modifiable risk factors to improve patient outcomes when providing medical care.

密苏里州的产妇死亡率仍然是全国最高的。认识到采取纠正措施的负担不仅仅取决于产科医生,现在是时候考虑怀孕在分娩前、分娩中和分娩后对患者的影响了。回顾妊娠史和妊娠意向可以解决可改变的风险因素,从而在提供医疗服务时改善患者的预后。
{"title":"Pregnant for Nine Months, Postpartum for Life: Long-term Implications of Pregnancy Related Conditions.","authors":"Helen Suzanne Hill, Kelly Jo Sandri","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Maternal mortality in the state of Missouri remains among the highest in the nation. Recognizing that the burden of making corrective actions does not rest solely with obstetric providers, it is time to consider how pregnancy affects our patients before, during, and after childbirth. Reviewing pregnancy history and pregnancy intention can be a chance to address modifiable risk factors to improve patient outcomes when providing medical care.</p>","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 5","pages":"389-395"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing Health Care for Good: Building Resilience to Tackle Burnout and Suicide for Physicians and Students. 向好的方向改变医疗保健:为医生和学生建立应对倦怠和自杀的韧性。
Pub Date : 2025-09-01
Marc B Hahn
{"title":"Changing Health Care for Good: Building Resilience to Tackle Burnout and Suicide for Physicians and Students.","authors":"Marc B Hahn","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 5","pages":"357-358"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravenous Fluids in Hospitalized Patients: A Review of Best Practices. 住院病人静脉输液:最佳做法综述
Pub Date : 2025-09-01
J Lane Wilson, Matthew Decker, Chelsie Cain

Judicious use of intravenous fluids in hospitalized patients can improve outcomes and prevent adverse events. For many clinical scenarios, balanced crystalloids have some advantages over normal saline, though the differences in outcomes are small. Excessive administration of normal saline can cause metabolic acidosis and kidney injury. For conditions with sodium and/or chloride deficits, normal saline is preferred. Hypertonic saline is used to rapidly correct severe acute hyponatremia, and hypotonic fluids are indicated for replacement of free water deficits. Intravenous albumin is indicated in only specific scenarios in the setting of cirrhosis and does not seem to have significant advantages for routine volume resuscitation over crystalloids. When intravenous fluids are administered, patient response should be closely monitored to guide subsequent therapy.

住院患者明智地使用静脉输液可改善预后并预防不良事件。在许多临床情况下,平衡晶体比生理盐水有一些优势,尽管结果的差异很小。过量使用生理盐水可引起代谢性酸中毒和肾损伤。对于钠和/或氯缺乏的情况,首选生理盐水。高渗盐水用于快速纠正严重的急性低钠血症,低渗液体用于补充游离水不足。静脉注射白蛋白仅适用于肝硬化的特定情况,在常规容量复苏中似乎没有晶体药物的显著优势。静脉输液时,应密切监测患者反应,以指导后续治疗。
{"title":"Intravenous Fluids in Hospitalized Patients: A Review of Best Practices.","authors":"J Lane Wilson, Matthew Decker, Chelsie Cain","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Judicious use of intravenous fluids in hospitalized patients can improve outcomes and prevent adverse events. For many clinical scenarios, balanced crystalloids have some advantages over normal saline, though the differences in outcomes are small. Excessive administration of normal saline can cause metabolic acidosis and kidney injury. For conditions with sodium and/or chloride deficits, normal saline is preferred. Hypertonic saline is used to rapidly correct severe acute hyponatremia, and hypotonic fluids are indicated for replacement of free water deficits. Intravenous albumin is indicated in only specific scenarios in the setting of cirrhosis and does not seem to have significant advantages for routine volume resuscitation over crystalloids. When intravenous fluids are administered, patient response should be closely monitored to guide subsequent therapy.</p>","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 5","pages":"396-402"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1 Picture = 1,000 Words. 1张图片= 1000字
Pub Date : 2025-09-01
{"title":"1 Picture = 1,000 Words.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 5","pages":"358"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Missouri Medicine Annual Statement of Ownership, Management & Circulation. 密苏里医药年度所有权,管理和流通报表。
Pub Date : 2025-09-01
{"title":"<i>Missouri Medicine</i> Annual Statement of Ownership, Management & Circulation.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 5","pages":"378"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543330/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nitazenes: An Old Drug Class Causing New Problems. nitazene:一种引起新问题的老药物。
Pub Date : 2025-07-01
Evan S Schwarz, Frank Dicker, Emilie Lothet, Hannah Spungen, Michael Levine

The illicit opioid supply is increasingly adulterated with novel synthetic opioids such as nitazenes. Nitazenes are very potent opioids and are increasingly associated with opioid overdoses and deaths. Despite their potency, nitazenes are reversed by naloxone. Given the high risk of overdose associated with these agents, improvements in the delivery of addiction care and naloxone distribution are needed to prevent morbidity and mortality from nitazenes and other novel opioids.

非法阿片类药物供应越来越多地掺入新型合成阿片类药物,如nitazene。nitazene是非常强效的阿片类药物,与阿片类药物过量和死亡的关系越来越密切。尽管它们很有效,但纳洛酮可以逆转尼塔尼。鉴于与这些药物相关的过量风险很高,需要改善成瘾治疗的提供和纳洛酮的分配,以防止nitazenes和其他新型阿片类药物的发病率和死亡率。
{"title":"Nitazenes: An Old Drug Class Causing New Problems.","authors":"Evan S Schwarz, Frank Dicker, Emilie Lothet, Hannah Spungen, Michael Levine","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The illicit opioid supply is increasingly adulterated with novel synthetic opioids such as nitazenes. Nitazenes are very potent opioids and are increasingly associated with opioid overdoses and deaths. Despite their potency, nitazenes are reversed by naloxone. Given the high risk of overdose associated with these agents, improvements in the delivery of addiction care and naloxone distribution are needed to prevent morbidity and mortality from nitazenes and other novel opioids.</p>","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 4","pages":"329-333"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Health: Health Forward Foundation, REACH Healthcare Foundation, and Missouri Foundation for Health. 社区健康:健康前进基金会、REACH医疗保健基金会和密苏里州健康基金会。
Pub Date : 2025-07-01
Charles W Van Way
{"title":"Community Health: Health Forward Foundation, REACH Healthcare Foundation, and Missouri Foundation for Health.","authors":"Charles W Van Way","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 4","pages":"266-269"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fake Science. 假科学。
Pub Date : 2025-07-01
Randy T Jackson
{"title":"Fake Science.","authors":"Randy T Jackson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 4","pages":"281-282"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Industry Patients: A Primary Care Perspective. 性产业患者:初级保健视角。
Pub Date : 2025-07-01
Mary Elizabeth Sutherland, Kristine Jennings, Gerrit Seymour, Daniel Armounfelder
{"title":"Sex Industry Patients: A Primary Care Perspective.","authors":"Mary Elizabeth Sutherland, Kristine Jennings, Gerrit Seymour, Daniel Armounfelder","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":74203,"journal":{"name":"Missouri medicine","volume":"122 4","pages":"255-258"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Missouri medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1